Study Connect Launches Healthcare User Research Platform

New platform helps companies validate product direction, workflow fit, and value stories before making expensive bets.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

Study Connect, a healthcare user research and product validation platform, has announced the launch of its platform to help life sciences and healthcare teams test concepts, workflows, usability, and value stories with clinicians, patients, caregivers, and other decision-makers. The platform aims to enable teams to validate product direction and reduce risk before making costly investments.

Why it matters

Healthcare product decisions are often made with partial information, while the cost of being wrong is unusually high. Study Connect's platform aims to help teams get the right mix of people, questions, and structure in place quickly to validate ideas and reduce risk early in the product development process.

The details

Study Connect's platform combines recruitment, study design support, session management, and reporting to deliver fast, medical-grade user research. The goal is to help teams align internal stakeholders faster and move into evidence building with clearer priorities. The company has already supported teams with go-to-market strategies in the US and Europe, and enabled product managers to formulate feature prioritization.

  • Study Connect announced the launch of its platform during WHX in Dubai on February 11, 2026.
  • The company recently completed a residency at Antler Japan (JPN5), where it developed the base advisory platform and moved into an AI-Powered User Research company.

The players

Study Connect

A healthcare user research and product validation platform that helps life sciences and healthcare teams test concepts, workflows, usability, and value stories with the people who use, buy, recommend, and approve products.

Matthew Mace

CEO and President of Study Connect Inc.

Aditi Gupta

Co-founder and CTO of Study Connect.

Got photos? Submit your photos here. ›

What they’re saying

“Speed matters, but only if the output is usable.”

— Aditi Gupta, Co-founder and CTO of Study Connect (einpresswire.com)

“Healthcare teams do not need more opinions; they need signal.”

— Matthew Mace, CEO and President of Study Connect (einpresswire.com)

What’s next

Study Connect plans to begin a seed round in March 2026 to accelerate growth across product development, research operations, and partnerships. The funding will support deeper platform capabilities, expanded coverage across clinical areas and geographies, and faster delivery for customers.

The takeaway

Study Connect's platform aims to help healthcare and life sciences teams validate product direction, workflow fit, and value stories before making expensive bets, reducing risk and improving readiness for scale in an increasingly competitive and evidence-driven market.